Ukko raised €33M in a Series B round in Jan 2021. The company is based in Palo Alto, Israel. Investors in the round: Leaps by Bayer. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
